SCHEMBL6256508

SCHEMBL6256508

COc1ccc(CCC(O)CN2C[CH]N(C3CCCCC3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
SLC18A2 Q05940 1/20 0.43
HTT P42858 2/20 0.42
CYP2D6 P10635 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CCR3 P51677 3/20 0.40
HRH3 Q9Y5N1 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
DRD4 P21917 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6259368 0.99 SLC18A2 (0.43) KMT2AALDH1A1TSHRKDM4EPOLB
SCHEMBL5222045 0.89 CYP2D6 (0.54) KMT2AALDH1A1TSHRKDM4EPOLB
SCHEMBL6256736 0.88 CYP2D6 (0.55) KMT2AALDH1A1TSHRKDM4EPOLB
SCHEMBL4509510 0.74 CYP1A2 (0.57) ALDH1A1TSHRKDM4EPOLBCYP2D6
SCHEMBL4490566 0.73 CYP1A2 (0.55) KMT2AALDH1A1TSHRKDM4EPOLB
SCHEMBL6258338 0.72 KCNH2 (0.47) KMT2AHTTCYP2D6SIGMAR1CCR3
SCHEMBL6261178 0.70 MEN1 (0.47) KMT2AALDH1A1KDM4EPOLBHTT
SCHEMBL6259496 0.69 RAB9A (0.54) KMT2AALDH1A1TSHRKDM4EPOLB
SCHEMBL7277594 0.69 HTT (0.56) KMT2AALDH1A1HTTMEN1
SCHEMBL8039062 0.66 HTT (0.58) KMT2AALDH1A1TSHRHTTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578737-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-09-28 EP disclosed
WO-2004063180-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2004-07-29 WO disclosed